Coeliac Disease in the Nord-Trøndelag Health Study (HUNT)
1 other identifier
interventional
56,000
1 country
1
Brief Summary
In this study, all citizen of Nord-Trøndelag County, Norway, above 20 years of age are invited to participate in a population-based health study, the HUNT study. Blood samples are drawn from the participants and assessed for celiac disease by a serological assay. Celiac disease is a chronic inflammatory disease of the small intestine due to dietary gluten in wheat, barley and rye. The diagnosis will be verified through endoscopic assessment and biopsies from the small intestinal mucosa. The aims of the study are 1) to establish the population-based prevalence of celiac disease; 2) to assess the consequences of the disease from patient reported outcomes, symptoms, deficiencies, and co-morbidity; 3) to study possible risk factors and environmental triggering events; 4) to identify genetic predictors and gene-environmental interactions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 17, 2019
CompletedFirst Submitted
Initial submission to the registry
July 30, 2019
CompletedFirst Posted
Study publicly available on registry
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedMay 25, 2025
May 1, 2025
5 years
July 30, 2019
May 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of celiac disease
the proportion of cases in the general population of Nord-Trøndelag County, Norway
1 year
Study Arms (1)
Endoscopy and biopsy
OTHERParticipants of the HUNT study with a positive serological assay for celiac disease are invited to attain a diagnostic endoscopy with duodenal biopsies
Interventions
Participants with a positive celiac serology are assessed by endoscopy and duodenal biopsy
Eligibility Criteria
You may qualify if:
- Participants of the forth round of the HUNT study
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- University of Oslocollaborator
- Oslo University Hospitalcollaborator
- Helse Nord-Trøndelag HFcollaborator
- University of Groningencollaborator
- Karolinska Institutetcollaborator
Study Sites (1)
Levanger Hospital, Nord-Trøndelag Hospital Trust
Levanger, Norway
Related Publications (1)
Lukina P, Andersen IL, Eggen PT, Mjones PG, Ronne E, Bolstad N, Klaasen RA, Warren DJ, Iversen R, Hveem K, Bernklev T, Jelsness-Jorgensen LP, Pedersen L, Jonkers I, Lagergren P, Sollid LM, Lundin K, Ness-Jensen E. Coeliac disease in the Trondelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients. BMJ Open. 2024 Jan 9;14(1):e077131. doi: 10.1136/bmjopen-2023-077131.
PMID: 38195172DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eivind Ness-Jensen, md phd
NTNU, Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2019
First Posted
August 1, 2019
Study Start
June 17, 2019
Primary Completion
July 1, 2024
Study Completion
July 1, 2024
Last Updated
May 25, 2025
Record last verified: 2025-05